AstraZeneca Seeks FDA Approval Of Preventive COVID-19 Antibody Treatment

The New York Times (10/5, Bengali) reports, “AstraZeneca said on Tuesday that it had asked the Food and Drug Administration to grant emergency authorization for a long-acting antibody treatment to prevent Covid-19 in people who are at high risk of the dis...